About Event

Connect with over 100 specialists in Upstream & Downstream Process Development, Analytical Development, CMC,  Manufacturing, and Drug Product at the 3rd mRNA Process Development & Manufacturing Summit Europe to drive innovation, establish key frameworks, and forge partnerships that tackle process, scale, and regulatory hurdles, ensuring the mRNA industry can continue to supercharge safe and effective mRNA drugs from research into the clinic and beyond.

FULL EVENT GUIDE

Hot Sessions for 2025:

  • Harness the use of Synthetic DNA and mRNA to shorten end-to-end production timelines, reduce waste and improve cost efficiency, ensuring regulatory compliance for safer and more effective mRNA therapeutics and vaccines with expertise from CureVac and Genevation
  • Detect deviations instantly and troubleshoot bottlenecks in real time by leveraging real-time process monitoring techniques to produce high quality mRNA drugs consistently. Shift from offline to in-line analytical techniques with Merck & University of Sheffield
  • Implement stabilisation techniques that extend shelf life and bridge the gap towards room temperature storage, reducing logistical challenges and increasing accessibility for patients with Ethris and Divincell
  • With LNP’s as the gold standard for mRNA formulation during the pandemic, leverage crucial insights into nextgen formulations including freeze, dried, liquid and non lipid based to enhance applications across a wider range of therapeutic areas with Altamira Tx
  • Join CEPI and BioNTech to ensure GMP compliance and achieve seamless scalability from small-batch personalised therapies to high volume production, meeting growing market demands while maintaining cost-efficiency

What's New?

Interactive Regulatory Panel Discussion

➜ Kickstart Day One, join leading regulatory experts to address burning questions on the evolving approval landscape for mRNA therapeutics and vaccines.

➜ Gain exclusive insights into the latest guidelines and end-to-end strategies to streamline your regulatory pathway, ensuring faster and smoother product approvals.

Pioneering Advances in Biotech

➜ Learn from pioneering biotechs Ceva, Altamira and Divincells, who will discuss next-gen formulations, both liquid & freeze dried, stabilization techniques and advanced purification processes, to optimize efficiency in scalable and cost-effective production, for reducing the time from lab to market.

Refreshed Speaker Faculty Including:

Covadonga Paneda

Chief Operating Officer

Altamira Therapeutics

Michael Anyadiegwu

CMC Technology Lead

CEPI

Sukrut Somani

Director - Chemistry Manufacturing & Controls

BioNTech

Daniela Daubert

Senior Director Process Development

Ethris GmbH

Géza Jakab

Head of Vaccine Formulation & Adjuvant Platform

Ceva Sante Animale

Markus Bergmann

Global Program Head Personalized Cancer Vaccines

CureVac SE

Connect with us - join the LinkedIn community
FULL EVENT GUIDE
REGISTER
PARTNER